Brief: Mateon says board now consists of six directors
27/10/2016 14:00
Oct 27 (Reuters) - Mateon Therapeutics Inc MATN.O
* Mateon expands board of directors with the appointments of
Donald R. Reynolds and Bobby W. Sandage, Jr., Ph.D.
* Mateon therapeutics inc - board now consists of six
directors, four of whom are independent
Source text for Eikon: ID:nGNXNKKWEa
Further company coverage: MATN.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas